論文業績
2023
2023
Original Articles
- T. Yamaguchi, D. Sako, T. Kurosawa, M. Nishijima, A. Miyano, Y. Kubo, S. Ohtsuki, K. Kawabata, Y. Deguchi: Development and Functional Evaluation of MDR1-expressing Microvascular Endothelial-like Cells Derived from Human iPS Cells as an In vitro Blood-brain Barrier Model. J Pharm Sci. 2023)
- S. Ito, R. Yagi, S. Ogata, T. Masuda, T. Saito, T. Saido, S. Ohtsuki: Proteomic alterations in the brain and blood-brain barrier during brain Abeta accumulation in an APP knock-in mouse model of Alzheimer’s disease. Fluids Barriers CNS. 20:66 (2023)
- N. Kajitani, M. Okada-Tsuchioka, A. Inoue, K. Miyano, T. Masuda, S. Boku, K. Iwamoto, S. Ohtsuki, Y. Uezono, J. Aoki, M. Takebayashi: G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression. Neuropsychopharmacology. 2023)
- Y. Sakurai, A. Ohtani, Y. Nakayama, M. Gomi, T. Masuda, S. Ohtsuki, H. Tanaka, H. Akita: Logistics and distribution of small extracellular vesicles from the subcutaneous space to the lymphatic system. J Control Release. 2023)
- S. Perlee, S. Kikuchi, T. Nakadai, T. Masuda, S. Ohtsuki, M. Matsumoto, B. Rahmutulla, M. Fukuyo, P. Cifani, A. Kentsis, R.G. Roeder, A. Kaneda, T. Hoshii: SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3. EMBO Rep. e57108 (2023)
- Y. Hamada, S. Ogata, T. Masuda, S. Ito, S. Ohtsuki: Development of a method for isolating brain capillaries from a single neonatal mouse brain and comparison of proteomic profiles between neonatal and adult brain capillaries. Fluids Barriers CNS. 20:50 (2023)
- R. Yagi, T. Masuda, S. Ito, S. Ohtsuki: Effect of antibiotic-administration period on hepatic bile acid profile and expression of pharmacokinetic-related proteins in mouse liver, kidney, and brain capillaries. Drug Metab Pharmacokin. 100494 (2023)
- T Masuda, N Araki, S Ohtsuki: Data for method development of water droplet-in-oil digestion approach. Journal of Proteome Data and Methods. 5:1 (2023)
